Lipid Nanoparticles for Delivery of Therapeutic RNA Oligonucleotides
Author:
Affiliation:
1. DTU Health Technology, 202 Kemitorvet, 2800 Kongens Lyngby, Denmark
2. DTU Chemistry, 206-207 Kemitorvet, 2800 Kongens Lyngby, Denmark
Funder
Villum Fonden
National Institute of Mental Health
H2020 European Research Council
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01290
Reference119 articles.
1. FDA-Approved Oligonucleotide Therapies in 2017
2. The potential of antisense oligonucleotide therapies for inherited childhood lung diseases
3. Eteplirsen in the treatment of Duchenne muscular dystrophy
4. Optimization of siRNA delivery to target sites: issues and future directions
5. Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Cited by 70 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cellular Alterations Due to Direct and Indirect Interaction of Nanomaterials with Nucleic Acids;International Journal of Molecular Sciences;2024-02-06
2. Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol;Journal of Controlled Release;2024-02
3. Recent advances and clinical translation of liposomal delivery systems in cancer therapy;European Journal of Pharmaceutical Sciences;2024-02
4. Bioinspired Spatiotemporal Management toward RNA Therapies;ACS Nano;2023-12-13
5. Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter;Cancers;2023-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3